1. Home
  2. CAL vs ALT Comparison

CAL vs ALT Comparison

Compare CAL & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAL
  • ALT
  • Stock Information
  • Founded
  • CAL 1878
  • ALT 1997
  • Country
  • CAL United States
  • ALT United States
  • Employees
  • CAL N/A
  • ALT N/A
  • Industry
  • CAL Shoe Manufacturing
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAL Consumer Discretionary
  • ALT Health Care
  • Exchange
  • CAL Nasdaq
  • ALT Nasdaq
  • Market Cap
  • CAL 424.1M
  • ALT 348.6M
  • IPO Year
  • CAL N/A
  • ALT N/A
  • Fundamental
  • Price
  • CAL $11.04
  • ALT $4.05
  • Analyst Decision
  • CAL Hold
  • ALT Strong Buy
  • Analyst Count
  • CAL 1
  • ALT 7
  • Target Price
  • CAL $14.00
  • ALT $16.50
  • AVG Volume (30 Days)
  • CAL 877.9K
  • ALT 2.8M
  • Earning Date
  • CAL 12-04-2025
  • ALT 11-06-2025
  • Dividend Yield
  • CAL 2.54%
  • ALT N/A
  • EPS Growth
  • CAL N/A
  • ALT N/A
  • EPS
  • CAL 1.76
  • ALT N/A
  • Revenue
  • CAL $2,652,908,000.00
  • ALT $20,000.00
  • Revenue This Year
  • CAL $1.74
  • ALT N/A
  • Revenue Next Year
  • CAL $5.85
  • ALT N/A
  • P/E Ratio
  • CAL $6.27
  • ALT N/A
  • Revenue Growth
  • CAL N/A
  • ALT N/A
  • 52 Week Low
  • CAL $10.51
  • ALT $2.90
  • 52 Week High
  • CAL $33.25
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • CAL 31.29
  • ALT 54.55
  • Support Level
  • CAL $12.15
  • ALT $3.93
  • Resistance Level
  • CAL $13.12
  • ALT $4.25
  • Average True Range (ATR)
  • CAL 0.57
  • ALT 0.18
  • MACD
  • CAL -0.11
  • ALT 0.00
  • Stochastic Oscillator
  • CAL 17.79
  • ALT 56.99

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: